Cover Image


Global Newborn Screening Market - Industry Analysis And Market Forecast (2015-2020)

出版商 Mordor Intelligence LLP 商品編碼 319330
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
Back to Top
全球新生兒篩檢市場:產業分析與市場預測 Global Newborn Screening Market - Industry Analysis And Market Forecast (2015-2020)
出版日期: 2016年01月01日 內容資訊: 英文

代謝性疾病和遺傳性疾病以各種形式妨礙嬰兒正常的身體,精神發展。現在透過簡單的血液檢驗,可判定是否最後成為問題的症狀。 早期診斷恰當治療,為未來發展帶來大幅差異。


第1章 概要

第2章 篩檢的最常見疾病

  • PKU
  • 先天性甲狀腺機能低下症
  • 半乳糖血症
  • 鐮形血球貧血症
  • 生物素酵素缺損
  • 先天性腎上腺增生症
  • 械槭糖漿尿症
  • 酪胺酸血症
  • 囊狀纖維化症
  • MCAD缺損
  • 弓蟲症
  • 聽覺篩檢

第3章 新生兒篩檢市場類別

  • 檢驗的種類
    • 血液檢驗
    • 聽力診斷
    • 先天性心臟病檢驗
    • 脈搏血氧飽和度

第4章 新生兒篩檢市場:各技術

  • 串聯式質譜分析
  • 血色素電泳檢驗
  • 免疫檢測及酵素化驗
  • 聽覺篩檢
  • 脈衝脈搏血氧飽和度篩檢

第5章 免責聲明



The Global Newborn Screening market is expected to reach USD XX million by 2020 growing at a CAGR of XX%. The newborn Screening is performed to screen infants after birth for detection of any health conditions or diseases that can be fatal but are not depicted during birth. The newborn screening tests are basically evaluation of metabolites and blood samples. The newborn screening tests varies according to different country jurisdictions. In many areas newborn screening test includes screening for hearing loss, congenital heart disease etc. The major diseases screened are sickle cell disease, cystic fibrosis, newborn hearing loss, congenital hypothyroidism, phenyl ketone urea, congenital heart disease, and others.

The presence of federal bodies for organizing awareness programmes, increasing awareness in developed countries, technological advancements in healthcare, and increasing array of newborn diseases are propelling the growth of this market. However, unawareness in developing countries, lack of trained professionals and socio-economic barriers in developing countries are posing restraint to the growth of this market.

The global newborn screening market have been segmented based on technology, product, and test type. The segmentation based on technology have been subdivided into tandem mass spectrometry, DNA based assay, enzyme and immunoassays, electrophoresis, hearing screening technology, and pulse Oximetry technology. The segmentation based on product sub-divided into newborn disorder screening instruments, hearing screening devices and accessories, Pulse Oximetry, and Reagents and assay kits. The segmentation based on Test Type have been sub-divided into critical congenital heart disease test, hearing screening test, and dry blood spot test.

The global Newborn screening test Market have been segmented based on geography as North America, Europe, Asia-Pacific, Middle East and North Africa, and South America. The segmentation on North America discusses different market trends, and market size of newborn screening tests in USA, Canada and Mexico. The Europe segment have been further subdivided into UK, France, Italy, Germany, Benelux, Scandinavia, Spain and Portugal. The segmentation on Asia-Pacific have been subdivided into China, Japan, India, South Korea, Australia, and New Zealand. The Middle-east & North Africa segment includes GCC, Egypt, and others. The South America region includes Brazil, Argentina, Colombia and others.

The technological advancement in healthcare and more physicians advising newborn screening test and increasing awareness amongst people are some crucial factors that are propelling the growth of this market. Amongst technology being used tandem mass spectrometry is expected to have the fasted growth rate during the forecast period. The Dry blood spot test has the largest market share amongst segmentation by test type. The key players in this market are Agilent Technologies, AB Sciex LLC, Covidien PLC, PerkinElmer Inc., Trivitron Healthcare, Bio-rad Laboratories, Masimo Corporation, Natus Medical, Waters Corporation and GE Healthcare.

Key deliverables of the study:

  • Market Definition for the specified topic along with identification of key drivers and restraints for the market.
  • Market analysis for the Global Newborn Screening test Market, with region specific assessments and competition analysis on a global and regional scale.
  • Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.
  • Identification and analysis of the Macro and Micro factors that affect the Global Newborn Screening test Market on both global and regional scale.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Table of Contents


  • Study deliverables
  • Market Definition
  • Sizing Units
  • Base Currency
  • Review and Forecast period years
  • General Study Assumptions

Research Methodology

  • Introduction
  • Analysis Methodology
  • Econometric Forecast Model
  • Research Assumptions

Executive Summary

Key Inferences

Market Overview and Industry trends

  • Current Market Senario
  • Newborn Screening test Applications
  • Technology Overview
  • New Developments
  • Industry Value chain analysis
  • product Life cycle analysis
  • Product Benchmarking
  • Investment Analysis
  • Porter's Five Forces

Drivers, Restraints, Opportunities, and challenges Analysis

  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Market Challenges

Global Newborn Screening Market segmentation

  • Introduction
  • Segmentation by Technology
  • Segmentation by Product
  • Segmentation by test type

Market segmentation by Geography - North America

  • North America
  • Europe
  • Asia-Pacific (APAC)
  • Middle-East and North Africa
  • South America

Competitive Landscape

  • Merger and acquisition analysis
  • New Product Launches
  • Agreements, Collaborations and Partnerships

Key Vendor Analysis

  • Agilent Technologies
  • AB Sciex LLC
  • Covidien PLC
  • PerkinElmer Inc.
  • Trivitron Healthcare
  • Bio-Rad Laboratories
  • Masimo Corporation
  • Natus Medical
  • Waters Corporation
  • GE Healthcare

Analyst outlook for Investment opportunities

Future Outlook of the market

Back to Top